| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
GSK
GlaxoSmithKline
|
Jun 08, 2026 | BUY |
Hold
-16.3% avg upside
19 analysts
|
— | +3.8% |
|
NVS
Novartis
|
Jun 04, 2026 | BUY |
Hold
-9.3% avg upside
24 analysts
|
$160.00
8.27% Upside
|
+1.7% |
|
ZTS
Zoetis
|
May 26, 2026 | HOLD |
Buy
+74.3% avg upside
22 analysts
|
— | -0.9% |
|
ABBV
AbbVie
|
May 13, 2026 | BUY |
Buy
+1.3% avg upside
43 analysts
|
$250.00
15.51% Upside
|
+6.1% |
|
MRK
Merck & Company
|
May 08, 2026 | BUY |
Strong Buy
+9.8% avg upside
43 analysts
|
$130.00
13.99% Upside
|
+4.4% |
|
RHHBY
Roche Holding
|
Apr 06, 2026 | BUY |
Buy
-1.9% avg upside
14 analysts
|
$55.00
10.54% Upside
|
+2.9% |
|
NVO
Novo Nordisk
|
Mar 20, 2026 | HOLD |
Buy
+166.9% avg upside
26 analysts
|
— | +24.5% |
|
UTHR
United Therapeutics
|
Mar 03, 2026 | BUY |
Buy
-20.4% avg upside
26 analysts
|
$560.00
3.61% Upside
|
+10.6% |
|
MRNA
Moderna
|
Jan 13, 2026 | HOLD |
Hold
+9.4% avg upside
38 analysts
|
— | +28.7% |
|
BIIB
Biogen
|
Jan 09, 2026 | HOLD |
Strong Buy
+24.4% avg upside
51 analysts
|
— | +5.9% |
|
BMY
Bristol-Myers Squibb
|
Jan 07, 2026 | HOLD |
Buy
+7.4% avg upside
42 analysts
|
— | +1.8% |
|
ELAN
Elanco Animal Health
|
Nov 19, 2025 | BUY |
Strong Buy
+25.3% avg upside
18 analysts
|
$25.00
2.66% Upside
|
+12.9% |
|
CH:ALC
Alcon
|
Oct 10, 2025 | BUY |
Buy
+35.5% avg upside
35 analysts
|
$67.36
29.78% Upside
|
· |
|
REGN
Regeneron
|
Jun 30, 2025 | HOLD |
Strong Buy
+27.5% avg upside
57 analysts
|
— | +17.7% |
|
GILD
Gilead Sciences
|
May 05, 2025 | BUY |
Strong Buy
-5.6% avg upside
66 analysts
|
$120.00
2.18% Downside
|
+33.3% |
|
ILMN
Illumina
|
Mar 28, 2025 | BUY |
Buy
-9.2% avg upside
30 analysts
|
$100.00
38.06% Downside
|
+47.1% |
|
BAX
Baxter International
|
Feb 24, 2025 | BUY |
Hold
+51.7% avg upside
23 analysts
|
$40.00
99.70% Upside
|
-40.1% |
|
TEVA
Teva Pharmaceutical
|
Jan 30, 2025 | BUY |
Buy
-8.1% avg upside
39 analysts
|
$20.00
35.92% Downside
|
+91.0% |
|
LLY
Eli Lilly & Co
|
Jan 22, 2025 | BUY |
Strong Buy
-11.2% avg upside
47 analysts
|
— | +45.3% |
|
VTRS
Viatris
|
Jan 06, 2025 | HOLD |
Buy
+47.2% avg upside
21 analysts
|
— | +9.0% |
|
AMGN
Amgen
|
Aug 20, 2024 | BUY |
Buy
-12.2% avg upside
57 analysts
|
$360.00
7.58% Upside
|
-7.5% |
|
SNY
Sanofi
|
Jul 26, 2024 | BUY |
Strong Buy
+74.8% avg upside
20 analysts
|
$60.00
42.08% Upside
|
+0.4% |
|
VRTX
Vertex Pharmaceuticals
|
Jun 17, 2024 | BUY |
Strong Buy
-3.9% avg upside
61 analysts
|
$550.00
21.49% Upside
|
-6.7% |
|
ITGR
Integer Holdings
|
Apr 29, 2024 | BUY |
Buy
+7.4% avg upside
15 analysts
|
$125.00
37.02% Upside
|
+10.8% |
|
INCY
Incyte
|
Apr 25, 2024 | BUY |
Buy
+1.0% avg upside
47 analysts
|
$70.00
28.00% Downside
|
+15.6% |
|
MDRX
Veradigm
|
Dec 07, 2022 | BUY |
Buy
+207.0% avg upside
22 analysts
|
$26.00
441.07% Upside
|
-31.3% |
|
EFX
Equifax
|
Oct 24, 2022 | BUY |
Strong Buy
+43.2% avg upside
38 analysts
|
$225.00
45.41% Upside
|
+8.9% |
|
LH
Labcorp Holdings
|
Sep 19, 2022 | HOLD |
Strong Buy
+0.7% avg upside
36 analysts
|
— | +7.9% |
|
DGX
Quest Diagnostics
|
Aug 17, 2022 | BUY |
Buy
-13.1% avg upside
33 analysts
|
$165.00
14.83% Downside
|
-2.1% |
|
ELV
Elevance Health
|
Feb 07, 2022 | BUY |
Strong Buy
+10.2% avg upside
32 analysts
|
$500.00
28.20% Upside
|
+7.4% |
|
IQV
IQVIA Holdings
|
Sep 10, 2021 | BUY |
Strong Buy
+33.0% avg upside
38 analysts
|
$290.00
75.05% Upside
|
-14.3% |
|
HCA
HCA Healthcare
|
Aug 02, 2021 | BUY |
Buy
+11.5% avg upside
35 analysts
|
$275.00
27.21% Downside
|
-15.0% |
|
BSX
Boston Scientific
|
Jun 07, 2021 | BUY |
Strong Buy
+73.9% avg upside
38 analysts
|
$50.00
10.50% Upside
|
-6.1% |
|
EBS
Emergent Biosolutions
|
May 05, 2021 | HOLD |
Buy
+211.6% avg upside
9 analysts
|
— | -47.1% |
|
BFH
Bread Financial Holdings
|
May 03, 2021 | BUY |
Buy
+33.8% avg upside
36 analysts
|
$135.00
31.46% Upside
|
-39.9% |
|
FISV
Fiserv
|
Jun 12, 2020 | BUY |
Buy
+109.8% avg upside
50 analysts
|
$115.00
139.46% Upside
|
+9.8% |
|
PRGO
Perrigo Company
|
Apr 17, 2020 | HOLD |
Buy
+577.3% avg upside
20 analysts
|
— | -18.2% |
|
LGND
Ligand Pharma
|
Mar 24, 2020 | HOLD |
Strong Buy
-18.2% avg upside
15 analysts
|
— | +92.9% |
|
MAN
ManpowerGroup
|
Oct 30, 2019 | HOLD |
Buy
+66.7% avg upside
16 analysts
|
— | -1.3% |
|
PINS
Pinterest
|
Aug 15, 2019 | BUY |
Strong Buy
+53.5% avg upside
45 analysts
|
$40.00
95.84% Upside
|
+8.3% |
|
FSLR
First Solar
|
Aug 31, 2016 | HOLD |
Buy
-14.0% avg upside
49 analysts
|
— | +24.2% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.